These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27319183)

  • 1. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders 4. Prevention and Therapeutic Treatment; 1) Prevention and management of fatty liver in daily life].
    Saibara T
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):406-10. PubMed ID: 27319183
    [No Abstract]   [Full Text] [Related]  

  • 2. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 5. Conclusion].
    Takeda J
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):422-3. PubMed ID: 27319186
    [No Abstract]   [Full Text] [Related]  

  • 3. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 2. Genetic and Environmental Susceptibility; 3) Epidemiology and large-scale clinical data analysis in metabolic diseases].
    Sone H
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):383-90. PubMed ID: 27319179
    [No Abstract]   [Full Text] [Related]  

  • 4. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 4. Prevention and Therapeutic Treatment; 3) Community healthcare in super-aged society].
    Yamada Y
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):417-21. PubMed ID: 27319185
    [No Abstract]   [Full Text] [Related]  

  • 5. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 4. Prevention and Therapeutic Treatment; 2) Practical and effective way of diet and exercise for treatment of diabetes based on chronometabolic science].
    Tanaka Y
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):411-6. PubMed ID: 27319184
    [No Abstract]   [Full Text] [Related]  

  • 6. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders 1. Preface].
    Kadowaki T
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):365-6. PubMed ID: 27319176
    [No Abstract]   [Full Text] [Related]  

  • 7. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders: 2. Genetic and Environmental Susceptibility; 1) The predisposition to impaired glucose metabolism].
    Yasuda K
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):367-75. PubMed ID: 27319177
    [No Abstract]   [Full Text] [Related]  

  • 8. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 2. Genetic and Environmental Susceptibility : 2) Genome and epigenome in obesity].
    Ogawa Y; Hashimoto K
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):376-82. PubMed ID: 27319178
    [No Abstract]   [Full Text] [Related]  

  • 9. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 3. Pathogenesis and Development of the Disease; 1) Pathophysiology and treatments for visceral fat obesity].
    Shimomura I
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):391-5. PubMed ID: 27319180
    [No Abstract]   [Full Text] [Related]  

  • 10. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 3. Pathogenesis and Development of the Disease; 3) Dissecting the relationship between an impairment of the feeding-regulatory system and obesity].
    Nakazato M
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):402-5. PubMed ID: 27319182
    [No Abstract]   [Full Text] [Related]  

  • 11. [The 43rd Scientific Meeting: Perspectives of Internal Medicine; Genetic predisposition and related life-style underlying metabolic disorders; 3. Pathogenesis and Development of the Disease; 2) Diabetes mellitus characterized by impaired insulin secretion in Japanese].
    Inagaki N
    Nihon Naika Gakkai Zasshi; 2016 Mar; 105(3):396-401. PubMed ID: 27319181
    [No Abstract]   [Full Text] [Related]  

  • 12. [Weight loss can cure fatty liver].
    Füeßl HS
    MMW Fortschr Med; 2015 Sep; 157(16):38. PubMed ID: 26783621
    [No Abstract]   [Full Text] [Related]  

  • 13. Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis.
    Lankarani KB; Alavian SM
    Gastroenterology; 2015 Dec; 149(7):1987-8. PubMed ID: 26515490
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply: To PMID 25865049.
    Vilar-Gomez E; Friedman SL; Romero-Gomez M
    Gastroenterology; 2015 Dec; 149(7):1988-9. PubMed ID: 26515488
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on treatment strategies in patients with non-alcoholic fatty liver disease.
    Petta S
    Curr Pharm Des; 2013; 19(29):5167-8. PubMed ID: 23394098
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D; Schattenberg JM
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Life style and liver diseases: discussion].
    Sato N; Hashimoto E; Yokoi Y; Kataoka E; Takei Y
    Nihon Naika Gakkai Zasshi; 2006 Jan; 95(1):100-17. PubMed ID: 16499216
    [No Abstract]   [Full Text] [Related]  

  • 18. Lifestyle advice in non-alcoholic fatty liver disease.
    Manco M; Marcellini M; Nobili V
    J Gastroenterol Hepatol; 2007 Apr; 22(4):604-5. PubMed ID: 17376064
    [No Abstract]   [Full Text] [Related]  

  • 19. Lifestyle intervention and fatty liver disease: the importance of both disrupting inflammation and reducing visceral fat.
    Malavazos AE; Gobbo G; Zelaschi RF; Cereda E
    Hepatology; 2010 Mar; 51(3):1091-2. PubMed ID: 19960554
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of non-alcoholic fatty liver disease: can we already face the epidemic?
    Verbeek J; Cassiman D; Lannoo M; Laleman W; van der Merwe S; Verslype C; Van Steenbergen W; Nevens F
    Acta Gastroenterol Belg; 2013 Jun; 76(2):200-9. PubMed ID: 23898557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.